Altana Pharma Sues Sun Again Over Heartburn Drug Patent

Law360, New York (August 18, 2005, 12:00 AM EDT) -- German drug maker Altana Pharma AG and its U.S. partner Wyeth Pharmaceuticals are once again suing Mumbai, India-based Sun Pharmaceuticals over plans to make generic versions of a popular drug for severe heartburn.

The new complaint, filed in U.S. District Court for New Jersey, addresses Sun’s alleged infringement of a patent used in covering a specific dosage and distribution method of Altana’s medication Protoxin.

In June, compelled by requirements in the Hatch-Waxman Act, Sun notified Altana and Wyeth of its intentions to create the generic version...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.